个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共36条记录  
  • Novel treatment concepts for graft-versus-host disease
    [作者:Wolf, D; von Lilienfeld-Toal, M; Wolf, AM; Schleuning, M; von Bergwelt-Baildon, M; Held, SAE; Brossart, P,期刊:Blood, 页码:16-25 , 文章类型: Review,,卷期:2012年119-1]
  • Acute and chronic graft-versus-host disease (GVHD) are potentially lethal complications after stem cell transplantation (SCT). Steroids are the appropriate first-line treatment for both. However, if patients do not adequ...
  • Tcl 1 interacts with Atm and enhances NF-kappa B activation in hematologic malignancies
    [作者:Gaudio, E; Spizzo, R; Paduano, F; Luo, ZH; Efanov, A; Palamarchuk, A; Leber, AS; Kaou, M; Zanesi, N; Bottoni, A; Costinean, S; Rassenti, LZ; Nakamura, T; Kipps, TJ; Aqeilan, RI; Pekarsky, Y; Trapasso, F; Croce, CM,期刊:Blood, 页码:180-187 , 文章类型: Article,,卷期:2012年119-1]
  • The T-cell leukemia/lymphoma 1 (TCL1) oncogene is a target of chromosomal translocations and inversions at 14q31.2, and its rearrangement in T cells causes T-cell prolymphocytic leukemias. TCL1 dysregulation in B cells i...
  • The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
    [作者:Arcaini, L; Zibellini, S; Boveri, E; Riboni, R; Rattotti, S; Varettoni, M; Guerrera, ML; Lucioni, M; Tenore, A; Merli, M; Rizzi, S; Morello, L; Cavalloni, C; Da Via, MC; Paulli, M; Cazzola, M,期刊:Blood, 页码:188-191 , 文章类型: Article,,卷期:2012年119-1]
  • The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with ...
  • Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation
    [作者:Tiacci, E; Schiavoni, G; Forconi, F; Santi, A; Trentin, L; Ambrosetti, A; Cecchini, D; Sozzi, E; di Celle, PF; Di Bello, C; Pulsoni, A; Foa, R; Inghirami, G; Falini, B,期刊:Blood, 页码:192-195 , 文章类型: Article,,卷期:2012年119-1]
  • Hairy cell leukemia (HCL) is a distinct clinicopathologic entity that responds well to purine analogs but is sometimes difficult to differentiate from HCL-like disorders (eg, splenic marginal zone lymphoma and HCL varian...
  • Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome inAML
    [作者:Treppendahl, MB; Qiu, XN; Sogaard, A; Yang, XJ; Nandrup-Bus, C; Hother, C; Andersen, MK; Kjeldsen, L; Mollgaard, L; Hellstrom-Lindberg, E; Jendholm, J; Porse, BT; Jones, PA; Liang, GN; Gronbaek, K,期刊:Blood, 页码:206-216 , 文章类型: Article,,卷期:2012年119-1]
  • Deletions of chromosome 5q are associated with poor outcomes in acute myeloid leukemia (AML) suggesting the presence of tumor suppressor(s) at the locus. However, definitive identification of putative tumor suppressor ge...
共36条记录 第一页 1 2 3 下一页 最后一页